论文部分内容阅读
目的探讨疏血通注射液治疗急性脑梗死患者的临床疗效。方法选取2013年11月至2014年10月海门市中医院神经内科收治的急性脑梗死患者40例作为试验组,给予疏血通注射液治疗;另选取2012年11月至2013年10月收治的急性脑梗死患者40例作为对照组,给予低分子右旋糖酐治疗,比较两组患者的临床疗效、血液流变学指标。结果试验组患者的总有效率为95.0%,明显高于对照组的77.5%,差异有统计学意义(P<0.05);试验组患者的全血黏度、血浆黏度、纤维蛋白原、血细胞比容均明显低于对照组,差异均有统计学意义(均P<0.05)。结论采用疏血通注射液治疗急性脑梗死,可有效改善患者的血液流变学及功能缺损症状,还有利于降低不良反应的发生率,安全可靠。
Objective To investigate the clinical effect of Shuxuetong injection in patients with acute cerebral infarction. Methods Forty patients with acute cerebral infarction admitted to Haimen Hospital of Traditional Chinese Medicine from November 2013 to October 2014 were selected as the experimental group and treated with Shuxuetong injection. The patients who were treated from November 2012 to October 2013 40 patients with acute cerebral infarction as a control group, given low-molecular dextran treatment, the clinical efficacy of two groups were compared, hemorheological indicators. Results The total effective rate of the experimental group was 95.0%, which was significantly higher than that of the control group (77.5%), the difference was statistically significant (P <0.05); the whole blood viscosity, plasma viscosity, fibrinogen, hematocrit Were significantly lower than the control group, the differences were statistically significant (P <0.05). Conclusion Shuxuetong injection for acute cerebral infarction, can effectively improve the patient’s hemorheology and functional impairment symptoms, but also help to reduce the incidence of adverse reactions, safe and reliable.